摘要:
A monomeric adhesive composition includes a stabilized polymerizable monomer, such as a 1,1-disubstituted monomer, including a cyanoacrylate, and a wound healing agent, wherein the wound healing agent is 5,5-disubstitutedhydantoin, including phenytoin; and a method for making said composition.
摘要:
The present invention relates to combinations of a building material and a bath fluid for methods for directly printing visual-aid models or elements, in particular, for the use in the office or at home. Furthermore, the present invention relates to the polymers obtained by the reaction of the building material and the bath fluid and to elements or models produced from the combinations according to the present invention. The use of the combinations according to the present invention in rapid prototyping methods enables the production of elements having varying mechanical properties. Coloured elements can be obtained by adding colourants. The elements made from the building materials according to the present invention exhibit mechanical properties, a thermostability and accuracy in every detail, thus rendering them suitable as visual-aid models and discussion models for design, architectural, constructional and other blueprints. The surface quality, the rigidity and the hardness of the elements can be improved by post-treatment.
摘要:
This invention relates to cyanoacrylate-containing compositions that include, in addition to the cyanoacrylate component, certain accelerators to improve fixture speeds on certain substrates.
摘要:
An adhesive composition includes a polymerizable adhesive monomer and at least one antioxidant stabilizer, and/or a container for storing said monomer composition that includes an antioxidant stabilizer. The antioxidant stabilizer provides superior stabilization and shelf-life of the composition and/or the container, and may enhance wound healing properties of the monomer composition.
摘要:
A method for increasing the rate of polymerization of 2-octyl cyanoacrylate, or the rate of copolymerization of 2-octyl cyanoacrylate and a tri-telechelic star polymer comprising polyisobutylene terminated with cyanoacrylate groups (Ø(PIB-CA)3) to form a co-network, is provided. The method comprise initiating the polymerization of 2-octyl cyanoacrylate, or the copolymerization of 2-octyl cyanoacrylate and a tri-telechelic star polymer comprising polyisobutylene terminated with cyanoacrylate groups (Ø(PIB-CA)3) to form the co-network, with an initiator selected from the group consisting of cyclic tertiary aliphatic amines optionally dissolved in a non-aqueous solvent. The cyclic tertiary aliphatic amines are selected from the group consisting of azabicyclo[2.2.2]-octane (ABCO), and 1,4-diazabicyclo[2.2.2]-octane (DABCO).
摘要:
A 2-cyanoacrylate-based composition comprises a coloring material that changes color with curing of 2-cyanoacrylate. The composition has good visibility and excellent workability as it is colored before curing, and changes color with curing as it becomes colorless or light-colored after curing, thereby providing bonded, filled or surface treated portions with good appearance.
摘要:
An adhesive composition that contains a preservative is particularly useful as a medical adhesive and can include alkyl cyanoacrylate monomers. The preservative is preferably soluble in the monomer. The composition may optionally be sterilized by placing a mixture of a polymerizable adhesive monomer and a preservative in a container, sealing the container, and sterilizing the mixture and the container.
摘要:
A radiation-curable composition which includes a cyanoacrylate component or a cyanoacrylate-containing formulation; a metallocene component; and a polymerizingly effective amount of a photoinitiator to accelerate the rate of cure is provided.
摘要:
Alkyl cyanoacrylate compositions comprising at least one alkyl cyanoacrylate, a biocompatible plasticizer (preferably an acyl trialkyl citrate wherein the acyl group contains from 2 to 4 carbon atoms and each alkyl group contains from 4 to 6 carbon atoms), and SO2 as an anionic polymerization inhibitor are provided. These compositions are suitable for topical application to human skin.